Cargando…

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome

Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than the compara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eudy‐Byrne, Rena, Zane, Nicole, Adeniyi‐Jones, Susan C., Gastonguay, Marc R., Ruiz‐Garcia, Ana, Kaushal, Gagan, Kraft, Walter K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604235/ https://www.ncbi.nlm.nih.gov/pubmed/34080312 http://dx.doi.org/10.1111/cts.13074

Ejemplares similares

Corrigendum to: Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Single high-dose buprenorphine for opioid craving during withdrawal
por: Ahmadi, Jamshid, et al.
Publicado: (2018)

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
por: Tobacyk, Julia, et al.
Publicado: (2023)

Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants
por: Devlin, Lori A., et al.
Publicado: (2021)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
por: Simon, Alan E., et al.
Publicado: (2021)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Opioid Withdrawal Presenting as Delirium and Role of Buprenorphine: A Case Series
por: Das, Sourav, et al.
Publicado: (2017)

BUPRENORPHINE WITHDRAWAL SYNDROME
por: Tripathi, B.M., et al.
Publicado: (1995)

Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments
por: Tang, Fei, et al.
Publicado: (2021)

Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
por: Lund, Ingunn O, et al.
Publicado: (2012)

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
por: K. K., Adams, et al.
Publicado: (2022)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
por: Szczesniak, Laura M., et al.
Publicado: (2020)

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
por: Adams, K. K., et al.
Publicado: (2021)

Precipitated opioid withdrawal after buprenorphine administration in patients presenting to the emergency department: A case series
por: Spadaro, Anthony, et al.
Publicado: (2023)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
por: Stevens, Sarah, et al.
Publicado: (2021)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016)

A Novel Strategy for Attenuating Opioid Withdrawal in Neonates
por: Santoro, Giovanni C, et al.
Publicado: (2016)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl
por: Spadaro, Anthony, et al.
Publicado: (2022)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

Response to “Pharmacometric Approach to Evaluate Drug Dosing Adherence”
por: Ding, Junjie, et al.
Publicado: (2020)

Addressing drivers of healthcare utilization for neonatal opioid withdrawal syndrome
por: Glait, Megan, et al.
Publicado: (2022)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling
por: Hofmann, Daniela, et al.
Publicado: (2021)

Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
por: Esposito, Daina B., et al.
Publicado: (2022)

Successful Treatment of Opioid Dependence with Flexible Doses of Injectable Prolonged Release Buprenorphine
por: D'Agnone, Oscar
Publicado: (2019)

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome
por: Baldo, Brian A.
Publicado: (2022)

Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017
por: Eaves, Emery R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nmgts2t9dfuac9gns8ck6gtgdr